Clinical trial reportCancerPublished
A phase 1 study of ASTX727 plus talazoparib in patients with triple-negative or hormone resistant/HER2-negative metastatic breast cancer
Regional connection
Verified An author affiliation on the Europe PMC record names Coriell Institute for Medical Research. Affiliation source
- Institution
- Coriell Institute for Medical Research
- County
- Camden County
Publication record
- Type
- Clinical trial report
- Venue
- Cancer
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Phthalazines; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; DNA Methylation; Drug Resistance, Neoplasm; Adult; Aged; Middle Aged; Female; Triple Negative Breast Neoplasms; Poly(ADP-ribose) Polymerase Inhibitors
- PubMed ID
- 41980055
- PubMed Central ID
- PMC13078666
- Open access
- Yes, open
- Added to directory
- Source checked